as 11-14-2024 4:00pm EST
Founded: | 1987 | Country: | United States |
Employees: | N/A | City: | BOTHELL |
Market Cap: | N/A | IPO Year: | 1989 |
Target Price: | $27.83 | AVG Volume (30 days): | 407.6K |
Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.01 | EPS Growth: | N/A |
52 Week Low/High: | $11.40 - $28.88 | Next Earning Date: | 11-12-2024 |
Revenue: | $146,957,000 | Revenue Growth: | 16.40% |
Revenue Growth (this year): | -21.28% | Revenue Growth (next year): | 8.56% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Aebersold Sarah | BLFS | Chief Human Resources Officer | Oct 30 '24 | Sell | $23.15 | 203 | $4,699.45 | 60,700 | |
Berard Todd | BLFS | Chief Marketing Officer | Oct 30 '24 | Sell | $23.15 | 311 | $7,199.65 | 107,847 | |
Foster Karen A. | BLFS | Chief Quality and Operations | Oct 30 '24 | Sell | $23.15 | 277 | $6,412.55 | 157,291 | |
Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Oct 15 '24 | Sell | $23.23 | 20,000 | $464,500.00 | 317,716 | |
Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Sep 18 '24 | Sell | $24.69 | 20,000 | $493,700.00 | 317,716 | |
Richardson Garrie | BLFS | Chief Revenue Officer | Sep 16 '24 | Sell | $25.12 | 3,070 | $77,118.40 | 114,773 |
BLFS Breaking Stock News: Dive into BLFS Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
GuruFocus.com
2 days ago
Argus Research
2 days ago
Zacks
2 days ago
PR Newswire
2 days ago
PR Newswire
3 days ago
GuruFocus.com
4 days ago
Argus Research
9 days ago
The information presented on this page, "BLFS BioLife Solutions Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.